Sonoma Pharmaceuticals Quote - SNOA

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Current Price

2.69

Bid

2.46

Offer

2.85

Volume

0.00 Day's Range 0.00

2.44 52 Week Range 9.374

Market Cap

3.602M

Previous Close

2.69

Open

Last Trade

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

339,159

Shares Outstanding

1,339,170

Dividend Yield

PE Ratio

-0.75

Earnings Per Share (EPS)

-3.61

Revenue

12.74M

Net Profit

-4.84M

Sonoma Pharmaceuticals Inc is a specialty pharmaceutical company operating in the United States. It is engaged in identifying, developing and commercializing differentiated therapies to patients living with chronic skin conditions. The company focuses on the development and commercialization of ther... Sonoma Pharmaceuticals Inc is a specialty pharmaceutical company operating in the United States. It is engaged in identifying, developing and commercializing differentiated therapies to patients living with chronic skin conditions. The company focuses on the development and commercialization of therapeutic solutions in medical dermatology to treat skin conditions, such as acne, atopic dermatitis, and scarring. The key products of the company are Celacyn, Ceramax Skin Barrier Cream, Mondoxyne, Alevicyn, SebuDerm, Microcyn, and Microcyn which are available for various skin treatments such as scars, itchy skin, minor skin irritations, rashes and others. The company derives revenue from the sale of products in the United States, Latin America, Europe and other countries. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.sonomapharma.com

Headquarters

Dover, Delaware, USA

Founded

Sonoma Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker SNOA. The last closing price for Sonoma Pharmaceuticals was US$2.69. Over the last year, Sonoma Pharmaceuticals shares have traded in a share price range of US$ 2.44 to US$ 9.374.

Sonoma Pharmaceuticals currently has 1,339,170 shares in issue. The market capitalisation of Sonoma Pharmaceuticals is US$3.60 million. Sonoma Pharmaceuticals has a price to earnings ratio (PE ratio) of -0.75.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.05	-1.82481751825	2.74	2.8549	2.53	76531	2.66266777	CS
4	-0.04	-1.4652014652	2.73	3.04	2.52	62507	2.69969001	CS
12	-0.01	-0.37037037037	2.7	3.6	2.44	339159	2.96280663	CS
26	-2.97	-52.4734982332	5.66	6.4	2.44	514123	3.97495795	CS
52	-0.46	-14.6031746032	3.15	9.374	2.44	1662234	4.72479739	CS
156	-74.71	-96.5245478036	77.4	85	2.318	1147890	18.06061156	CS
260	-99.31	-97.362745098	102	390.8	2.318	985420	61.83430253	CS

SNOA - Frequently Asked Questions (FAQ)

What is the current Sonoma Pharmaceuticals share price?

The current share price of Sonoma Pharmaceuticals is US$ 2.69

How many Sonoma Pharmaceuticals shares are in issue?

Sonoma Pharmaceuticals has 1,339,170 shares in issue

What is the market cap of Sonoma Pharmaceuticals?

The market capitalisation of Sonoma Pharmaceuticals is USD 3.6M

What is the 1 year trading range for Sonoma Pharmaceuticals share price?

Sonoma Pharmaceuticals has traded in the range of US$ 2.44 to US$ 9.374 during the past year

What is the PE ratio of Sonoma Pharmaceuticals?

The price to earnings ratio of Sonoma Pharmaceuticals is -0.75

What is the cash to sales ratio of Sonoma Pharmaceuticals?

The cash to sales ratio of Sonoma Pharmaceuticals is 0.28

What is the reporting currency for Sonoma Pharmaceuticals?

Sonoma Pharmaceuticals reports financial results in USD

What is the latest annual turnover for Sonoma Pharmaceuticals?

The latest annual turnover of Sonoma Pharmaceuticals is USD 12.74M

What is the latest annual profit for Sonoma Pharmaceuticals?

The latest annual profit of Sonoma Pharmaceuticals is USD -4.84M

What is the registered address of Sonoma Pharmaceuticals?

The registered address for Sonoma Pharmaceuticals is 850 NEW BURTON ROAD, SUITE 201, DOVER, DELAWARE, 19904

What is the Sonoma Pharmaceuticals website address?

The website address for Sonoma Pharmaceuticals is www.sonomapharma.com

Which industry sector does Sonoma Pharmaceuticals operate in?

Sonoma Pharmaceuticals operates in the PHARMACEUTICAL PREPARATIONS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
SFHGSamfine Creation Holdings Group Ltd	US$ 1.62 (62.00%)	3.42M
ADSEADD TEC Energy PLC	US$ 23.39 (56.66%)	12
SXTP60 Degrees Pharmaceuticals Inc	US$ 0.9162 (53.47%)	3.13M
ORKAOruka Therapeutics Inc	US$ 19.99 (40.68%)	51
UNBUnion Bankshares Inc	US$ 41.00 (28.57%)	67
SBFGSB Finanical Group Inc	US$ 12.22 (-46.85%)	4
THRYThryv Holdings Inc	US$ 10.01 (-46.01%)	4
IROQIF Bancorp Inc	US$ 15.00 (-38.17%)	200
AURAAura Biosciences Inc	US$ 5.01 (-37.38%)	1
ELVNEnliven Therapeutics Inc	US$ 15.00 (-31.82%)	202
CYNCYNGN Inc	US$ 0.0843 (18.73%)	8.68M
SFHGSamfine Creation Holdings Group Ltd	US$ 1.62 (62.00%)	3.42M
SXTP60 Degrees Pharmaceuticals Inc	US$ 0.9162 (53.47%)	3.13M
RIMEAlgorhythm Holdings Inc	US$ 0.0256 (4.92%)	945.32k
AMDLGraniteShares 2X Long AMD Daily ETF	US$ 5.985 (-18.13%)	539.58k